ArticleInternational journal of women's health2025
Efficacy and Acceptability of Thermal Ablation in Patients with Positive Documented Visual Inspection with Acetic Acid (Do-VIA) Results.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the efficacy and acceptability of thermal ablation (TA) as a treatment modality in patients with positive Documented Visual Inspection with Acetic Acid (Do-VIA) results, in a low-resource clinical setting. Methods: A retrospective cohort study was conducted at the VIA clinic of Cipto Mangunkusumo National Referral Hospital (RSCM), Jakarta, Indonesia, from January to July 2024. Patients with positive VIA-DoVIA results were treated with thermal ablation therapy (also known as cold coagulation) and followed up for three months to assess clinical outcomes and acceptability. Results: Out of 99 patients who underwent VIA screening, 47 tested positive. Of these, 35 received thermal ablation therapy. Three months post-treatment, 25 patients tested negative on VIA, while only 3 patients remained VIA-positive. Patient-reported side effects included clear vaginal discharge (52%), vaginal discharge with blood spots (3%), itchy discharge (38%), and short-term vaginal spotting (7%). No severe adverse events were reported. Conclusion: Thermal ablation therapy appears to be an effective and well-tolerated alternative to cryotherapy for the treatment of cervical precancerous lesions. It demonstrates good efficacy, minimal side effects, and high acceptability among healthcare providers in low-resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.